MetLife Investment Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.9K | Buy |
|
|||||
|
2025
Q1 | $75.6K | Sell |
|
|||||
|
2024
Q4 | $173K | Hold |
|
|||||
|
2024
Q3 | $291K | Hold |
|
|||||
|
2024
Q2 | $267K | Buy |
|
|||||
|
2024
Q1 | $327K | Hold |
|
|||||
|
2023
Q4 | $137K | Hold |
|
|||||
|
2023
Q3 | $109K | Hold |
|
|||||
|
2023
Q2 | $136K | Hold |
|
|||||
|
2023
Q1 | $101K | Buy |
|
|||||
|
2022
Q4 | $64.4K | Sell |
|
|||||
|
2022
Q3 | $298K | Hold |
|
|||||
|
2022
Q2 | $313K | Hold |
|
|||||
|
2022
Q1 | $246K | Buy |
|
|||||
|
2021
Q4 | $217K | Hold |
|
|||||
|
2021
Q3 | $383K | Hold |
|
|||||
|
2021
Q2 | $453K | Hold |
|
|||||
|
2021
Q1 | $406K | Hold |
|
|||||
|
2020
Q4 | $664K | Hold |
|
|||||
|
2020
Q3 | $515K | Hold |
|
|||||
|
2020
Q2 | $580K | Buy |
|
|||||
|
2020
Q1 | $263K | Hold |
|
|||||
|
2019
Q4 | $315K | Hold |
|
|||||
|
2019
Q3 | $262K | Hold |
|
|||||
|
2019
Q2 | $230K | Buy |
|